Motif ID	Motif Logo	Scanned Score Distribution	Frequency of Motif	Replicability Score	Evolutionary Conservation Score	Gene Targets	Gene Ontology of CpGMM targets
CG_hsf1_promoter_p_RM_12_46_6			2	0.5	3.15E-04	HCK, NR1D2, NR2C2, PPP4R4	steroid hormone receptor activity [MF], respiratory burst after phagocytosis [BP], regulation of protein serine/threonine phosphatase activity [BP]
CG_hsf1_promoter_p_RM_16_13_2			2	0.5	4.11E-04	ATL1, RXRA	retinoic acid-responsive element binding [MF], vitamin D response element binding [MF], secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [BP], Golgi cis cisterna [CC], 9-cis retinoic acid receptor activity [MF], retinoic acid receptor activity [MF]
CG_hsf1_promoter_p_RM_14_59_3			3	0.75	3.09E-04	CR1	complement component C3b receptor activity [MF], positive regulation of serine-type endopeptidase activity [BP], negative regulation of complement activation, alternative pathway [BP], complement component C4b receptor activity [MF], complement component C3b binding [MF], negative regulation of serine-type endopeptidase activity [BP], complement component C4b binding [MF], negative regulation of complement activation, classical pathway [BP]
CG_hsf1_promoter_p_RM_14_51_4			2	0.5	4.86E-04	FOXJ2, PPP1CB, CHD7, ACVR2A, PKN1, SOX1, SKI, TGFBR2	negative regulation of transforming growth factor beta receptor signaling pathway [BP], palate development [BP], nose development [BP], transmembrane receptor protein serine/threonine kinase activity [MF], transmembrane receptor protein serine/threonine kinase signaling pathway [BP], transforming growth factor beta-activated receptor activity [MF], lens morphogenesis in camera-type eye [BP], pattern specification process [BP], epithelial cell migration [BP], camera-type eye development [BP], lens development in camera-type eye [BP]
CG_hsf1_promoter_p_RM_12_50_3			3	0.75	2.29E-04	SLC20A1, MET, DBH	chromaffin granule lumen [CC], high affinity inorganic phosphate:sodium symporter activity [MF], hepatocyte growth factor-activated receptor activity [MF]
CG_hsf1_promoter_p_RM_14_26_4			2	0.5	3.73E-04	YY1, GNAS, TREX1, HCK, POLI, SIRT1	negative regulation of prostaglandin biosynthetic process [BP], post-embryonic body morphogenesis [BP], PcG protein complex [CC], negative regulation of cellular response to testosterone stimulus [BP], establishment of chromatin silencing [BP], respiratory burst after phagocytosis [BP], DNA repair [BP], response to prostaglandin F stimulus [BP], negative regulation of cAMP-dependent protein kinase activity [BP], extrinsic to internal side of plasma membrane [CC]
CG_hsf1_promoter_p_RM_12_23_6			5	1.0	7.88E-05	CLN8, SKI	olfactory bulb development [BP], histone deacetylase inhibitor activity [MF], retina development in camera-type eye [BP], L-glutamate uptake involved in synaptic transmission [BP]
CG_hsf1_promoter_p_RM_12_44_4			4	0.75	3.27E-04	CORO1A, DSE, PLCB3	regulation of systemic arterial blood pressure [BP], negative regulation of actin nucleation [BP], chondroitin-glucuronate 5-epimerase activity [MF]
CG_hsf1_promoter_p_RM_12_128_3			3	0.75	2.64E-04	KIF19, PVRL2	plus-end specific microtubule depolymerization [BP], virion attachment, binding of host cell surface coreceptor [BP], axonemal microtubule depolymerization [BP]
CG_hsf1_promoter_p_RM_14_53_2			2	0.5	3.27E-04	CORO1A, DSE, PGS1, MYB	CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity [MF], positive regulation of histone H3-K9 methylation [BP], uropod organization [BP], chondroitin-glucuronate 5-epimerase activity [MF], endoplasmic reticulum [CC], negative regulation of actin nucleation [BP]
CG_hsf1_promoter_p_RM_12_89_3			2	0.5	3.27E-04	IL1R1, PLCB1	interleukin-1-mediated signaling pathway [BP]
CG_hsf1_promoter_p_RM_12_8_2			4	0.5	3.86E-04	CSF1	mammary gland fat development [BP]
CG_hsf1_promoter_p_RM_14_3_4			3	0.5	3.52E-04	FMNL2, STX4, SLC22A7, CDH1, PLEKHA8, EPB41L1	cortical actin cytoskeleton organization [BP], lateral loop [CC], basolateral plasma membrane [CC], trans-Golgi network [CC]
CG_hsf1_promoter_p_RM_16_17_2			4	0.5	2.47E-04	ILK, ACE, P2RX2	detection of hypoxic conditions in blood by carotid body chemoreceptor signaling [BP], terminal bouton [CC], regulation of smooth muscle cell migration [BP]
CG_hsf1_promoter_p_RM_14_7_10			6	0.75	5.43E-04	SIRT1, CEBPG, SP1, BHLHE22, PRKAA2, COL5A1, AANAT, DHX9	sequence-specific DNA binding RNA polymerase II transcription factor activity [MF], fatty acid homeostasis [BP], circadian rhythm [BP], eye morphogenesis [BP], enucleate erythrocyte differentiation [BP]
CG_hsf1_promoter_p_RM_14_83_5			3	0.75	3.72E-04	NLGN1, SPTAN1, ARPC5L, EGFR, MKL2, SHROOM2, SEPT7, PTPRJ, IGF1R	positive regulation of cytokinesis [BP], negative regulation of protein kinase B signaling cascade [BP], actin binding [MF], positive regulation of intracellular protein kinase cascade [BP], positive regulation of protein kinase B signaling cascade [BP], protein heterooligomerization [BP]
CG_hsf1_promoter_p_RM_12_90_6			3	0.5	2.26E-04	CACFD1	integral to synaptic vesicle membrane [CC]
CG_hsf1_promoter_p_RM_16_14_3			2	0.5	3.92E-04	TADA2B, TDRD3	chromatin binding [MF]
CG_hsf1_promoter_p_RM_16_20_3			2	0.5	4.90E-04	PBX3	anterior compartment pattern formation [BP], posterior compartment specification [BP]
CG_hsf1_promoter_p_RM_14_78_5			4	0.5	4.70E-04	PIM1, PKD2	positive regulation of cyclin-dependent protein kinase activity involved in G1/S [BP]
CG_hsf1_promoter_p_RM_12_87_2			4	0.75	4.80E-04	TGFBR1, IGF1R, MPST	3-mercaptopyruvate sulfurtransferase activity [MF], inactivation of MAPKK activity [BP], positive regulation of protein kinase B signaling cascade [BP], cyanate catabolic process [BP]
CG_hsf1_promoter_p_RM_14_4_5			3	0.5	4.49E-04	HSD3B7, TBC1D10C, SYNGAP1	Rab GTPase activator activity [MF], cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity [MF]
CG_hsf1_promoter_p_RM_12_92_3			3	0.75	1.45E-04	PDGFRA, AGK, ADRB1	beta1-adrenergic receptor activity [MF], platelet-derived growth factor alpha-receptor activity [MF], acylglycerol kinase activity [MF]
CG_hsf1_promoter_p_RM_12_11_5			4	0.75	2.97E-04	NKD1, KCNK3, SMO	otolith morphogenesis [BP], ventral midline determination [BP], detection of cell density by contact stimulus involved in contact inhibition [BP], positive regulation of non-canonical Wnt receptor signaling pathway via JNK cascade [BP], negative regulation of convergent extension involved in axis elongation [BP], mesenchymal to epithelial transition involved in metanephric renal vesicle formation [BP], open rectifier potassium channel activity [MF]
CG_hsf1_promoter_p_RM_12_69_5			2	0.5	2.51E-04	DLST	dihydrolipoyllysine-residue succinyltransferase activity [MF]
CG_hsf1_promoter_p_RM_14_37_3			3	0.5	3.35E-04	SART1, SOX1, SKI, IKZF1	positive regulation of cytotoxic T cell differentiation [BP], lens morphogenesis in camera-type eye [BP], positive regulation of neutrophil differentiation [BP]
CG_hsf1_promoter_p_RM_12_133_4			2	0.5	3.80E-04	GNAZ, GNAS, TRAF3	extrinsic to internal side of plasma membrane [CC], G-protein beta/gamma-subunit complex binding [MF], heterotrimeric G-protein complex [CC], internal side of plasma membrane [CC], post-embryonic body morphogenesis [BP]
CG_hsf1_promoter_p_RM_12_33_5			6	0.75	3.06E-04	FAM20B, CACNA1D, VAX2, SLC50A1, BAIAP2	glucoside transmembrane transporter activity [MF], axonogenesis [BP], membrane repolarization involved in regulation of SA node cell action potential [BP], glucoside transport [BP], voltage-gated calcium channel activity involved in regulation of cardiac muscle cell action potential [MF], phosphotransferase activity, alcohol group as acceptor [MF], voltage-gated calcium channel activity involved in regulation of SA node cell action potential [MF]
CG_hsf1_promoter_p_RM_12_54_8			2	0.5	3.53E-04	UTS2R, ADD1, HSPB1, ADRA2C	positive regulation of angiogenesis [BP], positive regulation of vasoconstriction [BP]
CG_hsf1_promoter_p_RM_16_11_2			3	0.5	2.65E-04	PDPK1, HTRA1, PINK1	negative regulation of transforming growth factor beta receptor signaling pathway [BP], 3-phosphoinositide-dependent protein kinase activity [MF], C3HC4-type RING finger domain binding [MF]
CG_hsf1_promoter_p_RM_12_95_3			5	0.75	2.34E-04	RNF5, ADPRHL2, INPPL1, AMD1, SLC9A3R1	ER-associated misfolded protein catabolic process [BP], adenosylmethionine decarboxylase activity [MF], renal phosphate ion absorption [BP], bile acid secretion [BP], S-adenosylmethioninamine biosynthetic process [BP], poly(ADP-ribose) glycohydrolase activity [MF], negative regulation of platelet-derived growth factor receptor signaling pathway [BP]
CG_hsf1_promoter_p_RM_12_60_5			2	0.5	3.13E-04	SPHK1	sphingoid catabolic process [BP]
CG_hsf1_promoter_p_RM_12_14_7			4	0.75	3.54E-04	MYB, ZFPM2, PAX2, ZBTB42, SKIL, PPARA, SMARCA2, NFIX, BTRC, NFIC	negative regulation of transcription from RNA polymerase II promoter [BP], negative regulation of transcription, DNA-dependent [BP]
CG_hsf1_promoter_p_RM_14_46_3			3	0.5	4.02E-04	PBX3, FLI1, MLLT10, GTF2H4, CNOT2, CBX2, CIRH1A	transcription, DNA-dependent [BP], gene expression [BP], RNA metabolic process [BP]
CG_hsf1_promoter_p_RM_12_97_4			4	0.75	4.39E-04	ITPKC, ITPKA	inositol-1,4,5-trisphosphate 3-kinase activity [MF]
CG_hsf1_promoter_p_RM_14_5_2			5	0.75	5.96E-04	MIF	phenylpyruvate tautomerase activity [MF], positive regulation of prostaglandin secretion involved in immune response [BP]
CG_hsf1_promoter_p_RM_12_43_7			4	0.75	3.65E-04	TRAF3, PCSK2, GZMM, RHBDL1, SMO, CTRC, TBX1, EIF4EBP2, HHEX, MAPKAPK3, RPS6KA1	muscle cell fate commitment [BP], eukaryotic initiation factor 4E binding [MF], semicircular canal morphogenesis [BP], embryonic viscerocranium morphogenesis [BP], TRIF-dependent toll-like receptor signaling pathway [BP], serine-type endopeptidase activity [MF], MyD88-independent toll-like receptor signaling pathway [BP]
CG_hsf1_promoter_p_RM_12_98_2			2	0.5	4.55E-04	MMP15	enzyme activator activity [MF]
CG_hsf1_promoter_p_RM_12_16_3			4	0.75	8.62E-05	GPX4	phospholipid-hydroperoxide glutathione peroxidase activity [MF]
CG_hsf1_promoter_p_RM_14_40_5			8	0.5	2.81E-04	CHRNA7, BSND, PRDX5	regulation of apoptosis involved in tissue homeostasis [BP], chloride channel regulator activity [MF], peroxynitrite reductase activity [MF]
CG_hsf1_promoter_p_RM_12_62_4			4	0.5	9.48E-05	ALPL	cementum mineralization [BP]
CG_hsf1_promoter_p_RM_14_70_3			3	0.5	2.68E-04	HHEX	repressing transcription factor binding [MF], hepatic duct development [BP]
CG_hsf1_promoter_p_RM_12_108_3			2	0.5	1.67E-04	SPTBN1, FHOD3	negative regulation of actin filament polymerization [BP], Golgi to plasma membrane protein transport [BP]
CG_hsf1_promoter_p_RM_12_25_3			6	0.75	4.39E-04	GTF2I, ESRRA, YAP1, CACNA1D	membrane repolarization involved in regulation of SA node cell action potential [BP], transcription initiation from RNA polymerase II promoter [BP]
CG_hsf1_promoter_p_RM_14_44_5			5	0.5	3.13E-04	MAN2B2, ST8SIA2, MAN2A1, CHD7, DGKZ	nose development [BP], N-glycan processing [BP], lipid phosphorylation [BP], mannose metabolic process [BP], alpha-mannosidase activity [MF]
CG_hsf1_promoter_p_RM_12_37_3			5	0.75	3.56E-04	HTRA2, CHD7	cognition [BP], adult walking behavior [BP]
CG_hsf1_promoter_p_RM_14_55_2			5	0.5	5.25E-04	SPRY1, CDC42, AACS	acetoacetate-CoA ligase activity [MF], negative regulation of epidermal growth factor receptor signaling pathway [BP], actin filament branching [BP], response to starvation [BP]
CG_hsf1_promoter_p_RM_14_9_5			4	0.5	4.29E-04	PKP4, SEPT7, SKI, PTPRJ, RALA, IGF1R	midbody [CC], positive regulation of cytokinesis [BP], cytokinesis [BP], myelination in peripheral nervous system [BP], negative regulation of protein kinase B signaling cascade [BP]
CG_hsf1_promoter_p_RM_12_137_4			3	0.75	1.65E-04	PNPLA3, ADK, CNP, SLC12A5	dATP biosynthetic process [BP], 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity [MF], adenosine kinase activity [MF], thermosensory behavior [BP], diolein transacylation activity [MF], mono-olein transacylation activity [MF]
CG_hsf1_promoter_p_RM_12_7_4			4	0.5	2.45E-04	TRAF3, MDK	defecation [BP], regulation of interferon-beta production [BP]
CG_hsf1_promoter_p_RM_12_99_1			2	0.5	2.62E-04	RDH10, PKDCC	bud elongation involved in lung branching [BP], negative regulation of Golgi to plasma membrane protein transport [BP]
CG_hsf1_promoter_p_RM_12_35_5			2	0.5	2.16E-04	NAT8L, NPL	N-acetylneuraminate lyase activity [MF], aspartate N-acetyltransferase activity [MF]
CG_hsf1_promoter_p_RM_12_5_6			4	0.75	2.77E-04	MOCOS, PVRL2	Mo-molybdopterin cofactor sulfurase activity [MF], virion attachment, binding of host cell surface coreceptor [BP]
CG_hsf1_promoter_p_RM_12_106_3			2	0.5	2.90E-04	TNRC6A, OGG1	8-oxo-7,8-dihydroguanine DNA N-glycosylase activity [MF], gene expression [BP], oxidized purine nucleobase lesion DNA N-glycosylase activity [MF]
CG_hsf1_promoter_p_RM_12_27_5			5	1.0	3.81E-04	GAA, CLYBL	maltose metabolic process [BP], sucrose metabolic process [BP], diaphragm contraction [BP], vacuolar sequestering [BP], citrate (pro-3S)-lyase activity [MF]
CG_hsf1_promoter_p_RM_12_52_4			3	0.75	2.75E-04	GALNT11, GALNT10	polypeptide N-acetylgalactosaminyltransferase activity [MF]
CG_hsf1_promoter_p_RM_12_81_3			4	0.75	3.08E-04	BMPR1B, SOCS2, PRDM16	neurogenesis [BP], JAK pathway signal transduction adaptor activity [MF], SMAD binding [MF]
CG_hsf1_promoter_p_RM_12_74_1			3	0.5	4.63E-04	ADORA2B, PHF2, FOXP4, NFATC1	RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity [MF], negative regulation of chromatin silencing at rDNA [BP], positive regulation of chronic inflammatory response to non-antigenic stimulus [BP]
CG_hsf1_promoter_p_RM_14_21_3			2	0.5	2.91E-04	GCDH, GMPS, PDPK1	glutaryl-CoA dehydrogenase activity [MF], 3-phosphoinositide-dependent protein kinase activity [MF], GMP synthase (glutamine-hydrolyzing) activity [MF], GMP synthase activity [MF]
CG_hsf1_promoter_p_RM_14_56_3			2	0.5	5.94E-04	SMARCB1, CHD7, WDTC1, ACVR1B, ZFP1, ZNF84, BMPR1B, CNOT8, ZNF462, HOXC8	transforming growth factor beta-activated receptor activity [MF], development of primary female sexual characteristics [BP], regulation of transcription, DNA-dependent [BP], transcription, DNA-dependent [BP], receptor signaling protein serine/threonine kinase activity [MF], in utero embryonic development [BP], skeletal system development [BP], transmembrane receptor protein serine/threonine kinase activity [MF], gene expression [BP], RNA metabolic process [BP], regulation of transcription from RNA polymerase II promoter [BP]
CG_hsf1_promoter_p_RM_12_68_3			3	0.75	4.45E-04	AMD1, BMPR1B, PIKFYVE, TGFBR1	receptor complex [CC], adenosylmethionine decarboxylase activity [MF], transforming growth factor beta receptor activity, type I [MF], transforming growth factor beta-activated receptor activity [MF], 1-phosphatidylinositol-3-phosphate 5-kinase activity [MF], transmembrane receptor protein serine/threonine kinase activity [MF]
CG_hsf1_promoter_p_RM_12_127_7			4	0.75	5.05E-04	KCNK3, SLC44A1	open rectifier potassium channel activity [MF], phosphatidylcholine biosynthetic process [BP]
CG_hsf1_promoter_p_RM_12_47_2			3	0.75	4.16E-04	LHX2, CD4, VEGFA, TYRO3, BCL3, BRPF3	Bcl3-Bcl10 complex [CC], positive regulation of transcription, DNA-dependent [BP], platelet activation [BP], basophil chemotaxis [BP], induction by virus of host cell-cell fusion [BP], positive regulation of gene expression [BP], protein palmitoleylation [BP]
CG_hsf1_promoter_p_RM_14_54_2			2	0.5	3.01E-04	DLST	dihydrolipoyllysine-residue succinyltransferase activity [MF]
CG_hsf1_promoter_p_RM_12_59_5			4	0.75	4.30E-04	HMGA1, POLD1	base-excision repair [BP]
CG_hsf1_promoter_p_RM_12_121_4			3	0.75	2.05E-04	ZNF205, DRAXIN, AGRN	positive regulation of hydrogen peroxide biosynthetic process [BP], positive regulation of mitochondrial outer membrane permeabilization [BP], commissural neuron differentiation in spinal cord [BP], positive regulation of synaptic growth at neuromuscular junction [BP]
CG_hsf1_promoter_p_RM_12_45_3			2	0.5	3.75E-04	CAMK1D	regulation of granulocyte chemotaxis [BP]
CG_hsf1_promoter_p_RM_14_12_3			4	0.5	4.55E-04	DSE	chondroitin-glucuronate 5-epimerase activity [MF]
CG_hsf1_promoter_p_RM_16_2_6			8	0.5	6.02E-04	BMPR2, PRKAA2, AEBP2, SIRT1	ESC/E(Z) complex [CC], regulation of glucose metabolic process [BP], cellular response to starvation [BP], fatty acid homeostasis [BP], negative regulation of TOR signaling cascade [BP], positive regulation of autophagy [BP]
CG_hsf1_promoter_p_RM_12_125_3			4	0.75	2.63E-04	XPOT, DLST	dihydrolipoyllysine-residue succinyltransferase activity [MF], tRNA export from nucleus [BP]
CG_hsf1_promoter_p_RM_12_49_6			3	0.75	2.27E-04	RPS6KB1	response to testosterone stimulus [BP]
CG_hsf1_promoter_p_RM_12_10_3			3	0.5	3.99E-04	PTPRM, HHEX, GAA, CTNNB1	cadherin binding [MF], primary lung bud formation [BP], tongue morphogenesis [BP], epithelial tube branching involved in lung morphogenesis [BP], repressing transcription factor binding [MF]
CG_hsf1_promoter_p_RM_12_91_3			4	0.75	2.44E-04	MPG, GYG2, SWI5	DNA-7-methylguanine glycosylase activity [MF], DNA-7-methyladenine glycosylase activity [MF], glycogenin glucosyltransferase activity [MF], Swi5-Sfr1 complex [CC], DNA-3-methylguanine glycosylase activity [MF], DNA-3-methyladenine glycosylase activity [MF]
CG_hsf1_promoter_p_RM_12_102_7			6	0.75	3.95E-04	LMO4, PAX7	spinal cord association neuron differentiation [BP]
CG_hsf1_promoter_p_RM_12_9_4			3	0.75	3.27E-04	SC5DL, GPI	cholesterol biosynthetic process via lathosterol [BP], lathosterol oxidase activity [MF], methylglyoxal biosynthetic process [BP], glucose-6-phosphate isomerase activity [MF]
CG_hsf1_promoter_p_RM_12_135_4			4	0.75	3.73E-04	SLC11A1, MDK	divalent metal ion export [BP], metal ion:hydrogen antiporter activity [MF], defecation [BP], cellular cadmium ion homeostasis [BP], nitrite transport [BP], tertiary granule membrane [CC]
CG_hsf1_promoter_p_RM_12_12_3			4	0.75	1.82E-04	GPX4, LRRK2, RHOQ	GBD domain binding [MF], phospholipid-hydroperoxide glutathione peroxidase activity [MF], external side of mitochondrial outer membrane [CC], negative regulation of branching morphogenesis of a nerve [BP], GTP-dependent protein kinase activity [MF]
CG_hsf1_promoter_p_RM_14_69_6			4	0.5	1.00E-04	GPD1L	positive regulation of protein localization to cell surface [BP], NADH metabolic process [BP], regulation of ventricular cardiac muscle cell membrane depolarization [BP], negative regulation of protein kinase C signaling cascade [BP], glycerol-3-phosphate dehydrogenase complex [CC], glycerol-3-phosphate catabolic process [BP], glycerol-3-phosphate dehydrogenase [NAD+] activity [MF]
CG_hsf1_promoter_p_RM_14_50_3			5	0.5	2.20E-04	RYR2, BMPR1B	BMP signaling pathway [BP], establishment of protein localization to endoplasmic reticulum [BP]
CG_hsf1_promoter_p_RM_12_100_2			2	0.5	2.82E-04	SGPL1, PI4K2A, KLHL24	AP-3 adaptor complex binding [MF], sphinganine-1-phosphate aldolase activity [MF], host cell presynaptic membrane [CC], basophil degranulation [BP], perikaryon [CC]
CG_hsf1_promoter_p_RM_12_41_4			4	0.75	2.60E-04	CDC42, GTF2I, CELSR2, CAV1, RNF138	Wnt receptor signaling pathway [BP], mitogen-activated protein kinase binding [MF], maintenance of protein location in cell [BP], positive regulation of peptidyl-serine phosphorylation [BP], positive regulation of metalloenzyme activity [BP], actin filament branching [BP], protein kinase binding [MF]
CG_hsf1_promoter_p_RM_14_6_2			4	0.5	3.50E-04	AK4, INHBB	tetracycline metabolic process [BP], negative regulation of hepatocyte growth factor biosynthetic process [BP], host cell surface receptor binding [MF], carbon tetrachloride metabolic process [BP]
CG_hsf1_promoter_p_RM_12_115_5			3	0.5	3.67E-04	CASR, PLCB3	phosphatidylinositol phospholipase C activity [MF], phospholipase C activity [MF]
CG_hsf1_promoter_p_RM_12_4_6			5	0.75	2.76E-04	PHAX, TMEM181	toxin binding [MF]
CG_hsf1_promoter_p_RM_12_55_3			3	0.5	3.42E-04	PGS1	CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity [MF]
CG_hsf1_promoter_p_RM_14_31_4			4	0.5	4.91E-04	ACTR3	regulation of myosin II filament organization [BP]
CG_hsf1_promoter_p_RM_12_134_4			4	0.5	2.18E-04	SOD1, EPN1, SSC5D, CACNA1D, CARM1, SLC35A1, DIO3, RARA	growth plate cartilage development [BP], membrane repolarization involved in regulation of SA node cell action potential [BP], voltage-gated calcium channel activity involved in regulation of cardiac muscle cell action potential [MF], voltage-gated calcium channel activity involved in regulation of SA node cell action potential [MF], intracellular estrogen receptor signaling pathway [BP], cytoplasm [CC], thyroxine 5-deiodinase activity [MF], CMP-N-acetylneuraminate transmembrane transporter activity [MF], endochondral bone morphogenesis [BP], histone H3-R17 methylation [BP], histone methyltransferase activity (H3-R17 specific) [MF], CMP-N-acetylneuraminate transport [BP], Sertoli cell fate commitment [BP]
CG_hsf1_promoter_p_RM_14_64_2			3	0.5	3.30E-04	CDK5R1, DLX1, IGF1R	inactivation of MAPKK activity [BP], hippocampus development [BP]
CG_hsf1_promoter_p_RM_12_57_3			5	0.75	4.04E-04	SIVA1, HPN, CACNA1G, PDPK1	3-phosphoinositide-dependent protein kinase activity [MF], CD27 receptor binding [MF], response to nickel cation [BP], basement membrane disassembly [BP]
CG_hsf1_promoter_p_RM_14_66_2			2	0.5	1.92E-04	DDIT4, IDNK, SOX8	gluconokinase activity [MF], shikimate kinase activity [MF], D-gluconate catabolic process [BP], retinal rod cell differentiation [BP], defense response to virus [BP], renal vesicle induction [BP]
CG_hsf1_promoter_p_RM_12_117_4			3	0.75	3.65E-04	ITSN1, PLXNA3, ZFPM1, EMX2, GLIS2, GATA3, SGPL1	hemopoiesis [BP], negative regulation of fat cell differentiation [BP], negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation [BP], sphinganine-1-phosphate aldolase activity [MF], mast cell differentiation [BP], RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription [MF], embryonic hemopoiesis [BP], hippocampus development [BP], negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation [BP], negative regulation of cell proliferation involved in mesonephros development [BP], positive regulation of protein kinase B signaling cascade [BP], renal system development [BP], regulation of histone H3-K27 methylation [BP], negative regulation of mast cell differentiation [BP], ventricular septum development [BP], negative regulation of interleukin-4 biosynthetic process [BP], cell differentiation [BP], RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription [MF]
CG_hsf1_promoter_p_RM_12_65_3			2	0.5	2.61E-04	MPST, SMOX, IL13RA1	norspermine:oxygen oxidoreductase activity [MF], interleukin-13 receptor complex [CC], 3-mercaptopyruvate sulfurtransferase activity [MF], N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity [MF]
CG_hsf1_promoter_p_RM_12_132_4			4	0.75	3.46E-04	CSGALNACT2	dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [BP]
CG_hsf1_promoter_p_RM_14_29_2			3	0.5	3.01E-04	IST1, MYOD1, GAA, PRDM16	diaphragm contraction [BP], tongue development [BP], virus budding from nuclear membrane by viral capsid re-envelopment [BP], sucrose metabolic process [BP], maltose metabolic process [BP], positive regulation of myoblast fusion [BP], vacuolar sequestering [BP]
CG_hsf1_promoter_p_RM_12_2_3			2	0.5	2.59E-04	VASP, ILK, SYNGAP1	SH3 domain binding [MF], dendritic shaft [CC]
CG_hsf1_promoter_p_RM_16_18_1			4	0.5	2.79E-04	RAC1, CREBRF	extrinsic to plasma membrane [CC], embryonic olfactory bulb interneuron precursor migration [BP], negative regulation of interleukin-23 production [BP], engulfment of apoptotic cell [BP], lamellipodium [CC], negative regulation of endoplasmic reticulum unfolded protein response [BP]
CG_hsf1_promoter_p_RM_12_28_5			5	0.75	3.09E-04	SKI, CACNA1H, MINK1, PLEKHF2, CHRNB1, FBXL15, TNKS2, NKD1, IGF1R, CELSR2, PDSS1, LMX1B, NR2C2, PPARA, PDE8B, NTN1, WNT1, PDE6C, ANGPTL4, GPX4, WNT5B, EME1, CDC42, VAX2	positive regulation of DNA replication [BP], frizzled-2 binding [MF], myotube differentiation [BP], canonical Wnt receptor signaling pathway [BP], muscle cell differentiation [BP], neuron fate determination [BP], metal ion binding [MF], behavioral response to nicotine [BP], Wnt receptor signaling pathway [BP], Wnt receptor signaling pathway, calcium modulating pathway [BP], convergent extension involved in axis elongation [BP], neuron differentiation [BP], positive regulation of embryonic development [BP], establishment of nucleus localization [BP], anterior/posterior pattern specification [BP], dorsal/ventral pattern formation [BP], multicellular organismal development [BP], axis specification [BP], cell differentiation [BP], nervous system development [BP]
CG_hsf1_promoter_p_RM_12_136_2			3	0.5	1.85E-04	OGG1, UBE2V2	UBC13-MMS2 complex [CC], 8-oxo-7,8-dihydroguanine DNA N-glycosylase activity [MF], oxidized purine nucleobase lesion DNA N-glycosylase activity [MF]
CG_hsf1_promoter_p_RM_12_21_3			4	0.75	2.70E-04	FBXO7	protein complex [CC]
CG_hsf1_promoter_p_RM_12_6_4			5	0.75	4.26E-04	KANK1, HINFP	transcription regulatory region DNA binding [MF], negative regulation of lamellipodium morphogenesis [BP]
CG_hsf1_promoter_p_RM_12_123_3			3	0.75	2.91E-04	SMOX, PBX3	anterior compartment pattern formation [BP], norspermine:oxygen oxidoreductase activity [MF], posterior compartment specification [BP], N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity [MF]
CG_hsf1_promoter_p_RM_12_111_2			3	0.75	3.90E-04	SMAD6, RPS6KA1	negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [BP]
CG_hsf1_promoter_p_RM_12_51_6			6	0.75	3.84E-04	PPARA, CHRNB1	regulation of glycolysis by positive regulation of transcription from RNA polymerase II promoter [BP], behavioral response to nicotine [BP], regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter [BP]
CG_hsf1_promoter_p_RM_12_22_2			2	0.5	3.25E-04	POLA1, FZR1, TRIM28, CARKD, BABAM1	positive regulation of DNA repair [BP], G2/M transition DNA damage checkpoint [BP], DNA repair [BP], leading strand elongation [BP], ATP-dependent NAD(P)H-hydrate dehydratase activity [MF]
CG_hsf1_promoter_p_RM_16_19_3			2	0.5	3.85E-04	PDSS1, CAD, MYB	aspartate binding [MF], aspartate carbamoyltransferase activity [MF], trans-hexaprenyltranstransferase activity [MF], positive regulation of histone H3-K9 methylation [BP], carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [MF], nuclear matrix [CC], carbamoyl phosphate biosynthetic process [BP], trans-octaprenyltranstransferase activity [MF], dihydroorotase activity [MF]
CG_hsf1_promoter_p_RM_12_29_11			6	0.75	4.84E-04	SOX1	core promoter sequence-specific DNA binding [MF]
CG_hsf1_promoter_p_RM_12_131_3			3	0.5	2.93E-04	AZU1	positive regulation of fractalkine biosynthetic process [BP], positive regulation of interleukin-1 beta biosynthetic process [BP]
CG_hsf1_promoter_p_RM_12_42_3			4	0.75	2.76E-04	SLC11A1, UGCG	divalent metal ion export [BP], metal ion:hydrogen antiporter activity [MF], cellular cadmium ion homeostasis [BP], ceramide glucosyltransferase activity [MF], nitrite transport [BP], tertiary granule membrane [CC]
CG_hsf1_promoter_p_RM_12_78_4			2	0.5	3.80E-04	NPAS3, ITGA6, CCM2, PIAS1, ITGAV, PAX2, DAB2IP	alphav-beta3 integrin-IGF-1-IGF1R complex [CC], cellular response to epidermal growth factor stimulus [BP], integrin complex [CC], integrin-mediated signaling pathway [BP], positive regulation of transcription, DNA-dependent [BP]
CG_hsf1_promoter_p_RM_12_113_8			3	0.5	2.64E-04	ATP2C1, ATP2A2, BMP1, CASR, BMPR1B	negative regulation of heart contraction [BP], calcium-transporting ATPase activity [MF], cellular calcium ion homeostasis [BP], cartilage condensation [BP]
CG_hsf1_promoter_p_RM_12_120_2			2	0.5	3.06E-04	D2HGDH	(R)-2-hydroxyglutarate dehydrogenase activity [MF]
CG_hsf1_promoter_p_RM_14_15_3			5	0.75	5.86E-04	B3GALT6, DGKZ	negative regulation of mitotic cell cycle [BP], galactosylxylosylprotein 3-beta-galactosyltransferase activity [MF]
CG_hsf1_promoter_p_RM_14_72_7			3	0.5	2.00E-04	CHD7, HSF1	positive regulation of multicellular organism growth [BP]
CG_hsf1_promoter_p_RM_14_22_2			3	0.5	4.41E-04	ATP2C1, RBPJ, INHBB	manganese-transporting ATPase activity [MF], cellular manganese ion homeostasis [BP], blood vessel endothelial cell fate specification [BP], host cell surface receptor binding [MF], recombinase activity [MF], negative regulation of hepatocyte growth factor biosynthetic process [BP], positive regulation of ephrin receptor signaling pathway [BP], Golgi calcium ion transport [BP], Golgi calcium ion homeostasis [BP]
CG_hsf1_promoter_p_RM_14_13_4			3	0.5	4.28E-04	SKI, TDRD7	lens morphogenesis in camera-type eye [BP]
CG_hsf1_promoter_p_RM_12_58_8			4	0.75	5.78E-04	AHCYL1, SLC27A4, FPGS	tetrahydrofolylpolyglutamate synthase activity [MF], one-carbon metabolic process [BP], nucleotide binding [MF]
CG_hsf1_promoter_p_RM_12_122_7			4	0.5	3.41E-04	FGFR3, EVC	endochondral bone growth [BP]
CG_hsf1_promoter_p_RM_12_73_4			2	0.5	4.00E-04	SKIL, FZR1	lens fiber cell differentiation [BP]
CG_hsf1_promoter_p_RM_14_2_4			4	0.5	3.97E-04	B4GALNT3	acetylgalactosaminyltransferase activity [MF]
CG_hsf1_promoter_p_RM_14_20_2			3	0.5	3.26E-04	FMN2, DIO3	meiotic chromosome movement towards spindle pole [BP], thyroxine 5-deiodinase activity [MF]
CG_hsf1_promoter_p_RM_12_75_4			2	0.5	2.45E-04	NLGN1, CADM3	heterophilic cell-cell adhesion [BP]
CG_hsf1_promoter_p_RM_14_74_2			2	0.5	2.49E-04	PLXNA1, ST8SIA2, SOX8, MET	axon guidance [BP], morphogenesis of a branching epithelium [BP], hepatocyte growth factor-activated receptor activity [MF]
CG_hsf1_promoter_p_RM_12_103_5			4	0.75	4.41E-04	AANAT	N-terminal protein amino acid acetylation [BP]
CG_hsf1_promoter_p_RM_12_39_10			3	0.5	3.20E-04	GPC1, SPRY1, SLC5A3, PPDPF, FMR1, CLN8, BAI1	central nervous system development [BP], multicellular organismal development [BP], negative regulation of fibroblast growth factor receptor signaling pathway [BP], peripheral nervous system development [BP], nervous system development [BP]
CG_hsf1_promoter_p_RM_12_67_3			3	0.5	4.33E-04	CORO1A, PRDX5	regulation of apoptosis involved in tissue homeostasis [BP], peroxynitrite reductase activity [MF], negative regulation of actin nucleation [BP], homeostasis of number of cells within a tissue [BP]
CG_hsf1_promoter_p_RM_12_40_5			3	0.75	3.21E-04	HHEX, S100P, EIF4EBP2, CUX2	eukaryotic initiation factor 4E binding [MF], cellular response to organic substance [BP], response to organic substance [BP]
CG_hsf1_promoter_p_RM_12_130_3			2	0.5	3.10E-04	GLCE, MSMO1	UDP-glucuronate 5'-epimerase activity [MF], heparosan-N-sulfate-glucuronate 5-epimerase activity [MF], C-4 methylsterol oxidase activity [MF]
CG_hsf1_promoter_p_RM_12_61_5			5	0.75	3.58E-04	SRRT, ZNF844, SLC2A4RG, DNM2, ZNF567, MORF4L1, ZNF441	regulation of transcription, DNA-dependent [BP]
CG_hsf1_promoter_p_RM_12_101_3			3	0.75	1.79E-04	CLIC6	D4 dopamine receptor binding [MF], D3 dopamine receptor binding [MF], D2 dopamine receptor binding [MF]
CG_hsf1_promoter_p_RM_12_126_4			2	0.5	3.27E-04	MOCS3, TRIO, MTHFD1L, PLK5, PFKP, HSP90AB1, MAGI3, ATP1A1, RPS6KB2, DNAH2	ATP binding [MF]
CG_hsf1_promoter_p_RM_12_48_5			3	0.75	5.44E-04	IST1	abscission [BP], virus budding from nuclear membrane by viral capsid re-envelopment [BP]
CG_hsf1_promoter_p_RM_14_36_11			4	0.75	4.82E-04	ITPR3, AP4M1, PVRL2, ATP2A2, SLC12A5	platelet dense tubular network membrane [CC], inositol hexakisphosphate binding [MF], thermosensory behavior [BP], virion attachment, binding of host cell surface coreceptor [BP], transporter activity [MF], calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential [MF]
CG_hsf1_promoter_p_RM_14_32_4			8	0.5	7.93E-05	L3MBTL1	SAM domain binding [MF], regulation of megakaryocyte differentiation [BP], nucleosomal histone binding [MF]
CG_hsf1_promoter_p_RM_16_3_7			8	0.5	5.84E-04	POU3F2, SIRT1, PRKAA2, ALMS1, BMPR2, AEBP2, POU3F3	ovulation [BP], regulation of glucose metabolic process [BP], cellular response to starvation [BP], fatty acid homeostasis [BP], positive regulation of autophagy [BP], negative regulation of TOR signaling cascade [BP], ESC/E(Z) complex [CC], forebrain ventricular zone progenitor cell division [BP], cerebral cortex radially oriented cell migration [BP], cellular response to nutrient levels [BP]
CG_hsf1_promoter_p_RM_12_19_10			3	0.5	3.01E-04	SNX30, SYNPO, INPPL1, NLGN1, GABRA5	postsynaptic membrane [CC], ruffle assembly [BP], phosphatidylinositol binding [MF]
CG_hsf1_promoter_p_RM_12_64_3			3	0.5	2.93E-04	PAPLN, TRHDE, ADAMTS19	metalloendopeptidase activity [MF]
CG_hsf1_promoter_p_RM_14_28_3			3	0.5	2.43E-04	CYP46A1	cholesterol 24-hydroxylase activity [MF]
CG_hsf1_promoter_p_RM_14_48_3			3	0.5	2.21E-04	MOCS3, TTLL3, CARKD, ST3GAL3	N-acetyllactosaminide alpha-2,3-sialyltransferase activity [MF], protein-glycine ligase activity [MF], URM1 activating enzyme activity [MF], ATP-dependent NAD(P)H-hydrate dehydratase activity [MF], protein-glycine ligase activity, initiating [MF]
CG_hsf1_promoter_p_RM_16_1_2			3	0.5	1.66E-04	PPCDC	phosphopantothenoylcysteine decarboxylase activity [MF]
CG_hsf1_promoter_p_RM_14_67_4			2	0.5	2.71E-04	CACNG4	voltage-gated calcium channel complex [CC]
CG_hsf1_promoter_p_RM_12_114_3			2	0.5	4.06E-04	SMOX, CREBRF	norspermine:oxygen oxidoreductase activity [MF], N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity [MF], negative regulation of endoplasmic reticulum unfolded protein response [BP]
CG_hsf1_promoter_p_RM_14_34_4			3	0.75	1.85E-04	SNX9	lipid tube assembly [BP]
CG_hsf1_promoter_p_RM_14_11_1			3	0.5	2.56E-04	FEN1	double-stranded DNA specific exodeoxyribonuclease activity [MF], DNA replication, removal of RNA primer [BP]
CG_hsf1_promoter_p_RM_14_33_10			8	0.5	4.25E-04	PIM1, PKD2	positive regulation of cyclin-dependent protein kinase activity involved in G1/S [BP]
CG_hsf1_promoter_p_RM_12_110_6			3	0.75	5.42E-04	PDPK1, AQP6	3-phosphoinositide-dependent protein kinase activity [MF], cytoplasmic membrane-bounded vesicle [CC], nitrate transmembrane transporter activity [MF]
CG_hsf1_promoter_p_RM_14_19_3			4	0.5	3.37E-04	FOXG1, CHD7, SS18L1, FOXA3	nose development [BP], chromatin modification [BP]
CG_hsf1_promoter_p_RM_12_1_5			5	0.75	4.27E-04	TWIST2, FGF2, ILK, NELL1	osteoblast differentiation [BP], positive regulation of osteoblast differentiation [BP]
CG_hsf1_promoter_p_RM_12_129_6			4	0.75	2.16E-04	NEK7, MAP1LC3B, PCNT, MAP1S, KIF25	microtubule [CC]
CG_hsf1_promoter_p_RM_12_79_3			2	0.5	2.07E-04	CRHR1, ADORA2A	positive regulation of apoptotic signaling pathway [BP], activation of adenylate cyclase activity [BP], eating behavior [BP]
CG_hsf1_promoter_p_RM_14_17_3			2	0.5	3.18E-04	SGPL1	sphinganine-1-phosphate aldolase activity [MF]
CG_hsf1_promoter_p_RM_12_71_2			2	0.5	3.39E-04	HTT, SLC12A5	neural plate formation [BP], thermosensory behavior [BP], diazepam binding [MF], learning [BP], lactate biosynthetic process from pyruvate [BP]
CG_hsf1_promoter_p_RM_12_38_4			3	0.75	3.35E-04	IKZF1, CPQ	metallodipeptidase activity [MF], positive regulation of neutrophil differentiation [BP]
CG_hsf1_promoter_p_RM_14_73_2			4	0.5	3.41E-04	SKI, USP42, RNF4	ubiquitin-dependent protein catabolic process [BP], PML body [CC]
CG_hsf1_promoter_p_RM_14_38_3			3	0.5	4.82E-04	B3GALT6	Golgi medial cisterna [CC], galactosylxylosylprotein 3-beta-galactosyltransferase activity [MF]
CG_hsf1_promoter_p_RM_14_58_2			4	0.5	2.22E-04	DIO3, GAPDH, SEPT2, RAB11FIP4	peptidyl-cysteine S-nitrosylase activity [MF], peptidyl-cysteine S-trans-nitrosylation [BP], cleavage furrow [CC], thyroxine 5-deiodinase activity [MF]
CG_hsf1_promoter_p_RM_12_84_6			3	0.5	2.62E-04	STUB1	ubiquitin ligase complex [CC]
CG_hsf1_promoter_p_RM_14_18_2			3	0.5	2.59E-04	HGSNAT	heparan-alpha-glucosaminide N-acetyltransferase activity [MF]
CG_hsf1_promoter_p_RM_12_36_4			5	0.75	1.52E-04	PAX2	glial cell differentiation [BP]
CG_hsf1_promoter_p_RM_14_27_3			3	0.5	3.94E-04	DUT, KLC3	dUTP diphosphatase activity [MF], dUMP biosynthetic process [BP], cardiolipin synthase activity [MF]
CG_hsf1_promoter_p_RM_14_79_2			2	0.5	1.24E-04	INHBB, AP4E1, SOX9, APC2, DACT1, LPIN1	regulation of catenin import into nucleus [BP], negative regulation of canonical Wnt receptor signaling pathway [BP], fat cell differentiation [BP], protein kinase A binding [MF], intrahepatic bile duct development [BP], regulation of cell proliferation involved in tissue homeostasis [BP], beta-catenin binding [MF], epithelial cell proliferation involved in prostatic bud elongation [BP], host cell surface receptor binding [MF], negative regulation of hepatocyte growth factor biosynthetic process [BP], negative regulation of Wnt receptor signaling pathway [BP], regulation of fat cell differentiation [BP], intracellular protein transport [BP]
CG_hsf1_promoter_p_RM_14_82_2			5	0.5	1.88E-04	SLC35A1	CMP-N-acetylneuraminate transport [BP], CMP-N-acetylneuraminate transmembrane transporter activity [MF]
CG_hsf1_promoter_p_RM_12_53_6			3	0.75	5.35E-04	BAHD1, SUV39H1	histone methyltransferase activity [MF], histone-lysine N-methyltransferase activity [MF], chromatin silencing complex [CC]
CG_hsf1_promoter_p_RM_14_65_4			2	0.5	3.40E-04	GABRG3, TDRD3, ZEB1, RXRA, GABRA5	GABA-A receptor activity [MF], gamma-aminobutyric acid signaling pathway [BP], transcription coactivator activity [MF]
CG_hsf1_promoter_p_RM_12_116_4			3	0.75	2.68E-04	E2F3, TGFBR1, ZIC2, DNM2, ATP7A, OGDH	pyramidal neuron development [BP], positive regulation of transcription, DNA-dependent [BP]
CG_hsf1_promoter_p_RM_16_5_1			4	0.5	4.70E-04	SUV420H2, SIX3, FOXF2	histone H4-K20 trimethylation [BP], RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity [MF]
CG_hsf1_promoter_p_RM_12_80_3			2	0.5	3.39E-04	PPARA, REST, PPARD, TCF25, ARID4A, HEY2, SMAD5	transcriptional repressor complex [CC], negative regulation of transcription from RNA polymerase II promoter [BP], negative regulation of transcription, DNA-dependent [BP], negative regulation of transcription regulatory region DNA binding [BP], sequence-specific DNA binding transcription factor activity [MF]
CG_hsf1_promoter_p_RM_14_30_3			2	0.5	1.94E-04	PPARD, SMO	mesenchymal to epithelial transition involved in metanephric renal vesicle formation [BP], linoleic acid binding [MF], otolith morphogenesis [BP], ventral midline determination [BP], detection of cell density by contact stimulus involved in contact inhibition [BP]
CG_hsf1_promoter_p_RM_12_66_6			3	0.75	5.24E-04	TSHZ1, FOXP4, FOXC1, BASP1	ureteric bud development [BP], pattern specification process [BP], metanephric mesenchyme development [BP], anterior/posterior pattern specification [BP], metanephros development [BP]
CG_hsf1_promoter_p_RM_12_88_4			4	0.5	3.41E-04	GALNT12, GALNT11, RAP1A, RAPGEFL1, ARHGAP5, PPP1R7	polypeptide N-acetylgalactosaminyltransferase activity [MF], small GTPase mediated signal transduction [BP], Rho protein signal transduction [BP], enzyme regulator activity [MF]
CG_hsf1_promoter_p_RM_12_118_4			3	0.75	2.13E-04	SLC11A1, METAP1	N-terminal protein amino acid modification [BP], mRNA stabilization [BP]
CG_hsf1_promoter_p_RM_14_41_8			4	0.75	2.36E-04	FSTL3, SKI	negative regulation of BMP signaling pathway [BP], negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway [BP], negative regulation of activin receptor signaling pathway [BP]
CG_hsf1_promoter_p_RM_14_63_3			2	0.5	4.20E-04	TRIM54, FOXG1, PTPRM, ID4, CTNNB1	hindbrain development [BP], cadherin binding [MF], positive regulation of neuroblast proliferation [BP], neuroblast proliferation [BP], forebrain development [BP], negative regulation of oligodendrocyte differentiation [BP], microtubule-based process [BP], cell-cell adherens junction [CC]
CG_hsf1_promoter_p_RM_14_68_5			2	0.5	2.94E-04	PTP4A3, TCF7L1	positive regulation of transcription from RNA polymerase II promoter during mitosis [BP], prenylated protein tyrosine phosphatase activity [MF]
CG_hsf1_promoter_p_RM_12_32_5			5	0.75	4.90E-04	CD83	positive regulation of CD4-positive, alpha-beta T cell differentiation [BP]
CG_hsf1_promoter_p_RM_14_52_10			3	0.5	5.26E-04	ERGIC1, RAB2A	endoplasmic reticulum-Golgi intermediate compartment membrane [CC]
CG_hsf1_promoter_p_RM_12_34_12			3	0.5	4.35E-04	VIL1	cytoplasmic actin-based contraction involved in cell motility [BP], lysophosphatidic acid binding [MF]
CG_hsf1_promoter_p_RM_14_43_3			3	0.5	3.62E-04	HTRA2, CHD7	adult walking behavior [BP]
CG_hsf1_promoter_p_RM_12_96_8			2	0.5	2.90E-04	ACVR1B, NDST1, SMO, PPARD, RDH10, CBX2, SGPL1	skeletal system morphogenesis [BP], development of primary sexual characteristics [BP], embryonic neurocranium morphogenesis [BP], embryonic viscerocranium morphogenesis [BP], lipid binding [MF], hair follicle development [BP]
CG_hsf1_promoter_p_RM_12_24_7			4	0.75	3.82E-04	DYNLL2, DRD4	synaptic target recognition [BP], olfactory learning [BP]
CG_hsf1_promoter_p_RM_14_35_9			5	0.75	1.84E-04	GRIN3B, PALM, GRIN1	N-methyl-D-aspartate selective glutamate receptor complex [CC], synapse maturation [BP], outer membrane-bounded periplasmic space [CC], ionotropic glutamate receptor activity [MF], glycine binding [MF], neurotransmitter binding [MF], ionotropic glutamate receptor signaling pathway [BP], extracellular-glutamate-gated ion channel activity [MF]
CG_hsf1_promoter_p_RM_12_30_5			3	0.5	3.45E-04	NAT8L, AMDHD1, TAF1B	imidazolonepropionase activity [MF], aspartate N-acetyltransferase activity [MF], RNA polymerase I CORE element sequence-specific DNA binding transcription factor recruiting transcription factor activity [MF], RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript [BP], RNA polymerase I CORE element sequence-specific DNA binding [MF], RNA polymerase I core factor complex [CC]
CG_hsf1_promoter_p_RM_16_15_3			3	0.5	3.39E-04	PPM1L, SACM1L, LPIN1, MTMR14	phosphatidylinositol-3-phosphatase activity [MF], phospholipid metabolic process [BP], phosphatase activity [MF], glycerophospholipid biosynthetic process [BP]
CG_hsf1_promoter_p_RM_12_70_5			4	0.5	1.61E-04	CD1D, ZNF205, COASY, PRKCB, L3MBTL1	SAM domain binding [MF], antigen processing and presentation, endogenous lipid antigen via MHC class Ib [BP], positive regulation of mitochondrial outer membrane permeabilization [BP], histone binding [MF], pantetheine-phosphate adenylyltransferase activity [MF], positive regulation of hydrogen peroxide biosynthetic process [BP]
CG_hsf1_promoter_p_RM_14_8_6			4	0.5	5.37E-04	NTN1, PAFAH1B1, EPB41L5	cell leading edge [CC], extrinsic to membrane [CC], establishment of nucleus localization [BP], positive regulation of axon extension [BP]
CG_hsf1_promoter_p_RM_14_77_2			4	0.5	4.33E-04	NSD1, SKI, TDRD3	chromatin binding [MF], transcription cofactor activity [MF]
CG_hsf1_promoter_p_RM_14_25_2			5	0.5	2.42E-04	KLC3, HMGCR, IGF1R	hydroxymethylglutaryl-CoA reductase activity [MF], cardiolipin synthase activity [MF], inactivation of MAPKK activity [BP], protein tetramerization [BP], hydroxymethylglutaryl-CoA reductase (NADPH) activity [MF]
CG_hsf1_promoter_p_RM_14_45_5			5	0.5	3.07E-04	PHRF1	RNA polymerase binding [MF]
CG_hsf1_promoter_p_RM_12_94_2			4	0.75	4.82E-04	SETMAR	positive regulation of double-strand break repair via nonhomologous end joining [BP]
CG_hsf1_promoter_p_RM_16_10_1			1	0.25	2.82E-04	DTX1, SLC22A18, NOD2, CD4	T cell differentiation [BP], ubiquitin protein ligase binding [MF], macrophage inflammatory protein-1 alpha production [BP], detection of muramyl dipeptide [BP], activation of MAPK activity involved in innate immune response [BP], defense response to bacterium [BP], positive regulation of prostaglandin-endoperoxide synthase activity [BP], negative regulation of interleukin-18 production [BP], positive regulation of dendritic cell cytokine production [BP], regulation of T cell activation [BP], regulation of Notch signaling pathway [BP], positive regulation of peptidyl-tyrosine phosphorylation [BP], Notch signaling pathway [BP], positive regulation of prostaglandin-E synthase activity [BP], protein palmitoleylation [BP], negative regulation of toll-like receptor 2 signaling pathway [BP], induction by virus of host cell-cell fusion [BP], enzyme binding [MF], negative regulation of macrophage apoptotic process [BP], positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria [BP], microglial cell activation involved in immune response [BP], pathogen-associated molecular pattern dependent induction by symbiont of host innate immune response [BP], muramyl dipeptide binding [MF], cellular response to peptidoglycan [BP]
CG_hsf1_promoter_p_RM_14_23_4			4	0.75	3.49E-04	CDK5R1, NLGN1, STXBP5	positive regulation of exocytosis [BP], neuron cell-cell adhesion [BP]
CG_hsf1_promoter_p_RM_12_76_3			2	0.5	2.55E-04	DRD4, NDEL1, FZD10, RAC1, APCDD1	cerebral cortex radially oriented cell migration [BP], oligopeptidase activity [MF], Wnt-protein binding [MF], olfactory learning [BP], regulation of actin cytoskeleton organization [BP]
CG_hsf1_promoter_p_RM_14_47_2			3	0.5	4.64E-04	HHEX, DIO3, PTPRM	hepatic duct development [BP], negative regulation of angiogenesis [BP], thyroxine 5-deiodinase activity [MF]
CG_hsf1_promoter_p_RM_14_71_5			4	0.5	2.81E-04	CD83, FBXL15, LMX1B, SKI	dorsal/ventral pattern formation [BP], myotube differentiation [BP], positive regulation of CD4-positive, alpha-beta T cell differentiation [BP]